Cempra Inc. Presents Full Data Set of Phase 2 Clinical Trial of CEM-101 (Solithromycin) in Community-Acquired … – Yahoo Finance

The study also demonstrates solithromycin’s favorable safety and tolerability profile compared to levofloxacin. “This is the first time that the full data set of this Phase 2 trial has been available for review by the infectious disease …

Leave a Reply

Your email address will not be published.

*